SMTL ID : 7p41.1

Crystal Structure of human mARC1 A165T Variant

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.60 Å

Oligo State

monomer

Ligands

1 x EFK: oxidanyl(oxidanylidene)molybdenum(Non-covalent)

EFK.1: 6 residues within 4Å: Chain A: S.383, R.384, C.385, L.387, T.388 Ligands: MTE.2 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:R.384, A:R.384, A:C.385

1 x MTE: PHOSPHONIC ACIDMONO-(2-AMINO-5,6-DIMERCAPTO-4-OXO-3,7,8A,9,10,10A-HEXAHYDRO-4H-8-OXA-1,3,9,10-TETRAAZA-ANTHRACEN-7-YLMETHYL)ESTER(Non-covalent)

MTE.2: 24 residues within 4Å: Chain A: K.20, S.21, D.44, R.45, T.58, R.60, S.320, D.321, T.322, S.323, P.324, F.325, L.326, F.349, R.350, P.351, N.352, C.382, S.383, R.384, C.385, L.387, Y.429 Ligands: EFK.1 17 PLIP interactions: 17 interactions with chain A Hydrogen bonds: A:S.21, A:S.21, A:R.45, A:R.45, A:D.321, A:T.322, A:S.323, A:S.323, A:F.349, A:N.352, A:Y.429, A:Y.429 Water bridges: A:S.320 Salt bridges: A:K.20, A:D.44, A:R.45, A:R.350

1 x B3P: 2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-covalent)

B3P.3: 14 residues within 4Å: Chain A: E.92, D.101, T.102, E.103, T.107, G.111, H.112, L.113, D.151, A.154, A.155, F.185, Q.186, R.226 8 PLIP interactions: 8 interactions with chain A Hydrogen bonds: A:T.102, A:L.113, A:R.226 Water bridges: A:E.92, A:T.102, A:F.185, A:Q.186, A:Q.186

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.4: 4 residues within 4Å: Chain A: T.223, P.224, N.225, R.226 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Struwe, M.A. et al., Letter to the editor: The clinically relevant MTARC1 p.Ala165Thr variant impacts neither the fold nor active site architecture of the human mARC1 protein. Hepatol Commun (2022)

Release Date

2021-08-18

Peptides

Mitochondrial amidoxime-reducing component 1,Endolysin,Mitochondrial amidoxime-reducing component 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

Mitochondrial amidoxime-reducing component 1,Endolysin,Mitochondrial amidoxime-reducing component 1